A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

[1]  J. D. Santos.  Poorer Survival Outcomes for Male Breast Cancer Compared with Female Breast Cancer May Be Attributable to In-Stage Migration , 2012 .

[2]  Jonathan White,et al.  Male breast carcinoma: increased awareness needed , 2011, Breast Cancer Research.

[3]  A. Ashworth,et al.  Genetic Variants at Chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 Influence the Risk of Breast Cancer in Men , 2011, PLoS genetics.

[4]  M. Gariboldi,et al.  Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer , 2011, Breast Cancer Research and Treatment.

[5]  S. Neuhausen,et al.  Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States , 2011, Breast Cancer Research and Treatment.

[6]  S. Cole,et al.  Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study , 2010, Clinical Cancer Research.

[7]  Mitch Dowsett,et al.  Current and emerging biomarkers in breast cancer: prognosis and prediction. , 2010, Endocrine-related cancer.

[8]  Zhongyu Yuan,et al.  Chinese female breast cancer patients show a better overall survival than their male counterparts. , 2010, Chinese medical journal.

[9]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[10]  M. Dowsett,et al.  Comparative validation of the SP6 antibody to Ki67 in breast cancer , 2010, Journal of Clinical Pathology.

[11]  M. Dowsett,et al.  Influence of sex hormones on cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Speirs,et al.  Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms. , 2010, The Biochemical journal.

[13]  V. Speirs,et al.  Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. , 2010, Cancer research.

[14]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[15]  J. Bergh,et al.  Multidisciplinary meeting on male breast cancer: summary and research recommendations. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Wolff,et al.  The androgen receptor in breast cancer: learning from the past , 2010, Breast Cancer Research and Treatment.

[17]  G. Viale,et al.  Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers , 2010, Breast Cancer Research and Treatment.

[18]  Philip S Rosenberg,et al.  Male breast cancer: a population-based comparison with female breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Anghel,et al.  Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer. , 2010, Neoplasma.

[20]  Thomas Streichert,et al.  Identification of differentially expressed microRNAs in human male breast cancer , 2010, BMC Cancer.

[21]  Li Jia,et al.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. , 2009, Cancer research.

[22]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[23]  N. Sneige,et al.  Immunohistochemical characterization of subtypes of male breast carcinoma , 2009, Breast Cancer Research.

[24]  Stefano Volinia,et al.  MicroRNA expression profiling of male breast cancer , 2009, Breast Cancer Research.

[25]  V. Speirs,et al.  The rising incidence of male breast cancer , 2009, Breast Cancer Research and Treatment.

[26]  S. Conzen.  Minireview: nuclear receptors and breast cancer. , 2008, Molecular endocrinology.

[27]  I. Ellis,et al.  Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients , 2008, Clinical Cancer Research.

[28]  Takuji Iwase,et al.  Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  O. Fadare,et al.  Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases , 2006, Virchows Archiv.

[30]  D. Axelrod,et al.  Prognostic factors in node-negative male breast cancer. , 2006, Clinical breast cancer.

[31]  J. Soares,et al.  Evaluation of ERBB2 Gene Status and Chromosome 17 Anomalies in Male Breast Cancer , 2006, The American journal of surgical pathology.

[32]  C. Perou,et al.  Cytokeratin profiles of male breast cancers , 2006, Histopathology.

[33]  Z. Nahleh,et al.  Male breast cancer: a gender issue , 2006, Nature Clinical Practice Oncology.

[34]  V. Speirs,et al.  Steroid hormone receptor expression in male breast cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[36]  A. Livingstone,et al.  Male Breast Cancer: Is the Incidence Increasing? , 2004, Annals of Surgical Oncology.

[37]  G. Hortobagyi,et al.  Breast carcinoma in men , 2004, Cancer.

[38]  G. Bastert,et al.  Her-2/neu Gene Amplification and Protein Expression in Primary Male Breast Cancer , 2004, Breast Cancer Research and Treatment.

[39]  S. Toyoshima,et al.  Breast cancer in Japanese men: Does sex affect prognosis? , 2004, Breast cancer.

[40]  L. Brinton,et al.  Is Male Breast Cancer Similar or Different than Female Breast Cancer? , 2004, Breast Cancer Research and Treatment.

[41]  M. Teresiak,et al.  BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  Carlos Caldas,et al.  Molecular Classification of Breast Carcinomas Using Tissue Microarrays , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[43]  K. Bloom,et al.  Status of HER-2 in male and female breast carcinoma. , 2001, American journal of surgery.

[44]  G. Groisman,et al.  Angiogenesis, p53, and c‐erbB‐2 immunoreactivity and clinicopathological features in male breast cancer , 2000, Journal of surgical oncology.

[45]  D Barnes,et al.  Immunohistochemical detection of steroid receptors in breast cancer: a working protocol , 2000, Journal of clinical pathology.

[46]  G. Niehans,et al.  Prognostic Variables in Male Breast Cancer , 2000, The American surgeon.

[47]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[48]  L. Chiusa,et al.  Androgen receptor expression in male breast carcinoma: lack of clinicopathological association , 1999, British Journal of Cancer.

[49]  L. Kass,et al.  Proliferative activity and steroid hormone receptor status in male breast carcinoma , 1998, Journal of Steroid Biochemistry and Molecular Biology.

[50]  J. Donohue,et al.  Molecular markers in male breast carcinoma , 1998, Cancer.

[51]  I. Ellis,et al.  A comparison outcome of male breast cancer with female breast cancer. , 1997, American journal of surgery.

[52]  H. Sasano,et al.  Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[53]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[54]  S. Heys,et al.  Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[55]  M. Bm,et al.  Lobular carcinoma of the male breast , 1994 .

[56]  A. Niezabitowski,et al.  Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. , 1993, Oncology.

[57]  I. Fentiman,et al.  Male breast cancer. , 1993, British journal of hospital medicine.

[58]  S. Wolman,et al.  Immunocytochemical characterization of male breast cancer. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[59]  R. Blamey,et al.  Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up , 1992, Histopathology.

[60]  L. Holmberg,et al.  The survival pattern in male breast cancer. An analysis of 1429 patients from the nordic countries , 1989, Cancer.

[61]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[62]  G. MacKenzie,et al.  Long‐term survival following cancer of the male breast in Northern Ireland. A report of 81 cases , 1985, Cancer.

[63]  K. Ouriel,et al.  Prognostic factors of carcinoma of the male breast. , 1984, Surgery, gynecology & obstetrics.